Renee M. Chabin
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Peptidase Inhibition and Analysis, Diabetes Treatment and Management, Neuropeptides and Animal Physiology, Carbohydrate Chemistry and Synthesis, Nitric Oxide and Endothelin Effects
Most-Cited Works
- → Inhibitors of the bacterial cell wall biosynthesis enzyme Mur D(1998)77 cited
- → Specificity, stability, and potency of monocyclic .beta.-lactam inhibitors of human leukocyte elastase(1992)55 cited
- → Design and Synthesis of Prolylcarboxypeptidase (PrCP) Inhibitors To Validate PrCP As A Potential Target for Obesity(2010)51 cited
- → Substituted 2-aminopyridines as inhibitors of nitric oxide synthases(2000)47 cited
- → Active-Site Structure Analysis of Recombinant Human Inducible Nitric Oxide Synthase Using Imidazole(1996)47 cited
- → Engineering a Cell-Free Murein Biosynthetic Pathway: Combinatorial Enzymology in Drug Discovery(1998)36 cited
- → Inhibition of human serine proteases by substituted 2-azetidinones(1992)29 cited
- → Mechanism of Inhibition of Human Leukocyte Elastase by .beta.-Lactams. 3. Use of Electrospray Ionization Mass Spectrometry and Two-Dimensional NMR Techniques To Identify .beta.-Lactam-Derived E-I Complexes(1995)23 cited
- → Mechanism of inhibition of human leukocyte elastase by monocyclic .beta.-lactams(1993)22 cited
- → Mechanism of Inhibition of Human Leukocyte Elastase by .beta.-Lactams. 2. Stability, Reactivation Kinetics, and Products of .beta.-Lactam-Derived E-I Complexes(1995)21 cited